395 related articles for article (PubMed ID: 32599894)
1. Methylation-Based Therapies for Colorectal Cancer.
Cervena K; Siskova A; Buchler T; Vodicka P; Vymetalkova V
Cells; 2020 Jun; 9(6):. PubMed ID: 32599894
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of aberrant DNA methylation during colorectal cancer development.
Sakai E; Nakajima A; Kaneda A
World J Gastroenterol; 2014 Jan; 20(4):978-87. PubMed ID: 24574770
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies.
Weisenberger DJ; Liang G; Lenz HJ
Oncogene; 2018 Feb; 37(5):566-577. PubMed ID: 28991233
[TBL] [Abstract][Full Text] [Related]
4. Promoter methylation of ITF2, but not APC, is associated with microsatellite instability in two populations of colorectal cancer patients.
Savio AJ; Daftary D; Dicks E; Buchanan DD; Parfrey PS; Young JP; Weisenberger D; Green RC; Gallinger S; McLaughlin JR; Knight JA; Bapat B
BMC Cancer; 2016 Feb; 16():113. PubMed ID: 26884349
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic biomarkers in colorectal cancer diagnostics.
Rawson JB; Bapat B
Expert Rev Mol Diagn; 2012 Jun; 12(5):499-509. PubMed ID: 22702366
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic-based therapy for colorectal cancer: Prospect and involved mechanisms.
Rezapour S; Hosseinzadeh E; Marofi F; Hassanzadeh A
J Cell Physiol; 2019 Nov; 234(11):19366-19383. PubMed ID: 31020647
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer: epigenetic alterations and their clinical implications.
Puccini A; Berger MD; Naseem M; Tokunaga R; Battaglin F; Cao S; Hanna DL; McSkane M; Soni S; Zhang W; Lenz HJ
Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):439-448. PubMed ID: 28939182
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic insights in the diagnosis, prognosis, and treatment selection in CRC, an updated review.
Ghadiri Moghaddam F; Farajnia S; Karbalaei-Mahdi M; Monir L
Mol Biol Rep; 2022 Oct; 49(10):10013-10022. PubMed ID: 35727475
[TBL] [Abstract][Full Text] [Related]
9. The role of epigenetic therapies in colorectal cancer.
Baretti M; Azad NS
Curr Probl Cancer; 2018 Nov; 42(6):530-547. PubMed ID: 29625794
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation.
Coppedè F
Cancer Lett; 2014 Jan; 342(2):238-47. PubMed ID: 22202641
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of tumor suppressor lncRNA MEF2C-AS1 frequently happened in patients at all stages of colorectal carcinogenesis.
Qian S; Lin S; Xu X; Bai H; Yeerken A; Ying X; Li Z; Fei X; Yang J; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2022 Sep; 14(1):111. PubMed ID: 36064442
[TBL] [Abstract][Full Text] [Related]
12. Impact of Colon-Specific DNA Methylation-Regulated Gene Modules on Colorectal Cancer Patient Survival.
Yu H; Jiang W; Chen G; Yang F; Zhao X; Ji Z; Ni J; Fu Y; Chen F; Zhao B
Med Sci Monit; 2019 May; 25():3549-3557. PubMed ID: 31083646
[TBL] [Abstract][Full Text] [Related]
13. Temporal DNA methylation pattern and targeted therapy in colitis-associated cancer.
Li J; Su X; Dai L; Chen N; Fang C; Dong Z; Fu J; Yu Y; Wang W; Zhang H; Wang H; Ji Y; Liu Y; Cheng L; Shi G; Zhang S; Yang Y; Deng H
Carcinogenesis; 2020 Apr; 41(2):235-244. PubMed ID: 31802101
[TBL] [Abstract][Full Text] [Related]
14. Epigenetics and its therapeutic potential in colorectal cancer.
Oryani MA; Tavasoli A; Ghalavand MA; Ashtiani RZ; Rezaee A; Mahmoudi R; Golvari H; Owrangi S; Soleymani-Goloujeh M
Epigenomics; 2022 Jun; 14(11):683-697. PubMed ID: 35473313
[TBL] [Abstract][Full Text] [Related]
15. Drug resistance in colorectal cancer: An epigenetic overview.
Luo M; Yang X; Chen HN; Nice EC; Huang C
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188623. PubMed ID: 34481016
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine.
Fatemi N; Tierling S; Es HA; Varkiani M; Mojarad EN; Aghdaei HA; Walter J; Totonchi M
Int J Cancer; 2022 Dec; 151(12):2068-2081. PubMed ID: 35730647
[TBL] [Abstract][Full Text] [Related]
17. The impact of polyunsaturated fatty acids on DNA methylation and expression of DNMTs in human colorectal cancer cells.
Sarabi MM; Naghibalhossaini F
Biomed Pharmacother; 2018 May; 101():94-99. PubMed ID: 29477476
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.
Okugawa Y; Grady WM; Goel A
Gastroenterology; 2015 Oct; 149(5):1204-1225.e12. PubMed ID: 26216839
[TBL] [Abstract][Full Text] [Related]
19. Association of DNA methyltransferases expression with global and gene-specific DNA methylation in colorectal cancer cells.
Sarabi MM; Naghibalhossaini F
Cell Biochem Funct; 2015 Oct; 33(7):427-33. PubMed ID: 26416384
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation markers in colorectal cancer.
Kim MS; Lee J; Sidransky D
Cancer Metastasis Rev; 2010 Mar; 29(1):181-206. PubMed ID: 20135198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
